Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
Jazz Pharmaceuticals will webcast management fireside chats from four major September 2026 investor healthcare conferences for investors to access online.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Jazz Pharmaceuticals (JAZZ) will participate in fireside chats at four upcoming investor healthcare conferences in September 2026, hosted by Wells Fargo, Citi, Morgan Stanley and Deutsche Bank.
Audio webcasts of these sessions, and 30-day replays, will be accessible via the Investors section of the company’s website.
Details
News Market Reaction – JAZZ
On Sep 3, the first trading day after this news, JAZZ closed 0.81% above the previous close. Relative volume reached 2.5x the daily average during tracking.
Data tracked by StockTitan Argus for the Sep 3 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 1:30 p.m. ET
- Citi 2026 Biopharma Back to School Summit on Thursday, September 10, 2026, at 10:40 a.m. ET
- Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, at 12:20 p.m. ET
- Deutsche Bank Healthcare Summit on Wednesday, September 16, 2026, at 8:00 a.m. ET
Audio webcasts of the fireside chats will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. A replay of the webcasts will be archived on the website for 30 days.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with rare disease — often with limited or no therapeutic options. We have a diverse portfolio of medicines, including leading therapies addressing epilepsies, cancers and sleep disorders. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.
Contacts
Investors:
InvestorInfo@jazzpharma.com
Ireland +353 1 634 7800
U.S. +1 650 496 2717
Media:
CorporateAffairsMediaInfo@jazzpharma.com
Ireland +353 1 637 2141
U.S. +1 215 867 4948
View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-upcoming-investor-conferences-302868145.html
SOURCE Jazz Pharmaceuticals plc
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.